Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Together, these actions make IGF-1 LR3 effective for muscle recovery and growth (2)
GLP-1 inhibitor drugs, originally developed for managing type 2 diabetes, mimic hormones that regulate blood sugar levels, which can help decrease appetite and lower calorie intake
The metabolic profiling revealed that AOD9604 undergoes rapid proteolytic degradation in serum, generating a series of predictable fragment peptides
The two unfavorable votes were both for Emideltide
Omzo's brand materials describe tirzepatide as offering "dual-hormone support that targets appetite, blood sugar, and metabolism for deeper, sustained progress." Clinical trials of tirzepatide (the active ingredient in Zepbound and Mounjaro) have shown substantial weight loss outcomes in studied populations, and some trials have shown greater average weight reduction with tirzepatide compared to semaglutide in head-to-head comparisons - though individual responses vary and neither medication is appropriate for all patients
You may be a strong candidate if you meet the following criteria: BMI of 25 or higher No history of eating disorders (such as anorexia, bulimia, binge eating, or emotional eating) No personal or family history of thyroid cancer or Multiple Endocrine Neoplasia type 2 (MEN 2) No history of diabetic retinopathy Not currently taking any other form of GLP-1 18 years or older Not pregnant or breastfeeding Our medical team will review your full health history during your consultation to ensure the program is safe and appropriate for you
